Sarepta Therapeutics (SRPT) Capital Expenditures Growth (5y) (2015 - 2026)
Sarepta Therapeutics (SRPT) Capital Expenditures Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.71 Bn | 1.31 Bn | 622.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.11% |
| Dec 31, 2025 | -33.97% |
| Sep 30, 2025 | -1.95% |
| Jun 30, 2025 | 10.65% |
| Mar 31, 2025 | 36.77% |
| Dec 31, 2024 | 17.15% |
| Sep 30, 2024 | 31.63% |
| Jun 30, 2024 | 11.82% |
| Mar 31, 2024 | 14.81% |
| Dec 31, 2023 | -1.18% |
| Sep 30, 2023 | 8.11% |
| Jun 30, 2023 | 15.54% |
| Mar 31, 2023 | -4.86% |
| Dec 31, 2022 | 15.35% |
| Sep 30, 2022 | 60.83% |
| Jun 30, 2022 | 25.89% |
| Mar 31, 2022 | 4.45% |
| Dec 31, 2021 | -5.41% |
| Sep 30, 2021 | 61.54% |
| Jun 30, 2021 | 69.68% |